🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single arm, open-label, non-randomized and single-center phase II...
Status
Unknown
Location
Li Xu
Start Date
2020-08-01
Trial ID
NCT04454905
Treatments Being Tested
To evaluate the efficacy and immune microenvironment changes in advanced he...
Status
Recruiting
Location
Zhongshan Hospital, Fudan University
Start Date
2025-09-01
Trial ID
NCT07147101
Treatments Being Tested
A Trial to Evaluate the Efficacy and Safety of Camrelizumab Plus Rivocerani...
Status
Completed
Location
Zhongshan Hospital, Fudan University
Start Date
2022-09-01
Trial ID
NCT05367687
Treatments Being Tested
Adrenocortical carcinoma (ACC) is a rare aggressive malignant tumor. Accord...
Status
Recruiting
Location
West China Hospital
Start Date
2025-03-15
Trial ID
NCT06831175
Treatments Being Tested
This is a randomized, open-label, international, multi-center, phase III tr...
Status
Completed
Location
Beverly Hills Cancer Center
Start Date
2019-06-10
Trial ID
NCT03764293
A study to evaluate efficacy and safety of transarterial chemoembolization ...
Status
Active Not Recruiting
Location
Zhongshan Hospital, Fudan University
Start Date
2022-08-09
Trial ID
NCT05320692
Treatments Being Tested
To evaluate HAIC combined with Camrelizumab plus rivoceranib for advanced m...
Status
Recruiting
Location
Zhongshan Hospital, Fudan University
Start Date
2025-08-15
Trial ID
NCT07105748
Treatments Being Tested
1.1. Main Objectives The objective response rate (ORR) determined by the re...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-03-02
Trial ID
NCT07482670
The purpose of this phase 2/3 study is to investigate the efficacy and safe...
Status
Recruiting
Location
Harbin Medical University Cancer Hospital
Start Date
2025-02-20
Trial ID
NCT06796803
Treatments Being Tested
SABRE STUDY will explore effectiveness and safety of the combination therap...
Status
Unknown
Location
Zhongnan Hospital of Wuhan University
Start Date
2022-03-15
Trial ID
NCT04878107
Treatments Being Tested